HFNO Versus Face Mask for Cerebral Oxygenation During Procedural Sedation
NCT: NCT07718295 · RECRUITING
Brief Summary
This prospective randomized controlled trial aims to compare the effects of high-flow nasal oxygen (HFNO) and conventional face mask oxygen therapy on cerebral oxygenation during procedural sedation performed outside the operating room. Adult patients undergoing elective diagnostic or interventional procedures under procedural sedation will be randomly assigned to receive either HFNO or conventional face mask oxygen. Regional cerebral oxygen saturation will be continuously monitored using near-infrared spectroscopy (NIRS), while sedation depth will be assessed using the Patient State Index (PSI, SedLine) and the Modified Observer's Assessment of Alertness/Sedation (MOAA/S) scale. Secondary outcomes include peripheral oxygenation, ventilation parameters, arterial blood gas values, airway interventions, hemodynamic variables, and patient and practitioner satisfaction.
Frequently Asked Questions
What is HFNO Versus Face Mask for Cerebral Oxygenation During Procedural Sedation?
HFNO Versus Face Mask for Cerebral Oxygenation During Procedural Sedation is a clinical trial registered under NCT07718295. Current status: RECRUITING.
What is the status of NCT07718295?
The current status of NCT07718295 (HFNO Versus Face Mask for Cerebral Oxygenation During Procedural Sedation) is: RECRUITING.
When did HFNO Versus Face Mask for Cerebral Oxygenation During Procedural Sedation start?
HFNO Versus Face Mask for Cerebral Oxygenation During Procedural Sedation started on 2026-06-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.